TABLE OF CONTENTS
Volume 40, Issue 11 (December (1) 2007)
Review
Current status and future perspectives for yttrium-90 (90Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphoma FREE
C Gisselbrecht, W Bethge, R F Duarte, A M Gianni, B Glass, C Haioun, G Martinelli, A Nagler, R Pettengell, A Sureda, H Tilly and K Wilson
Bone Marrow Transplant 40: 1007-1017; advance online publication, October 8, 2007; doi:10.1038/sj.bmt.1705868
Original Articles
Stem Cell Collection
IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients FREE
M Magagnoli, M Spina, M Balzarotti, I Timofeeva, L Isa, M Michieli, R Capizzuto, E Morenghi, L Castagna, U Tirelli and A Santoro
Bone Marrow Transplant 40: 1019-1025; advance online publication, October 1, 2007; doi:10.1038/sj.bmt.1705862
Conditioning Regimens
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation FREE
D A Pollyea, A S Artz, W Stock, C Daugherty, L Godley, O M Odenike, E Rich, S M Smith, T Zimmerman, Y Zhang, D Huo, R Larson and K van Besien
Bone Marrow Transplant 40: 1027-1032; advance online publication, September 10, 2007; doi:10.1038/sj.bmt.1705852
Allografting
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14) FREE
M Hundemer, U Klein, D Hose, M-S Raab, F W Cremer, A Jauch, A Benner, C Hei
, M Moos, A D Ho and H Goldschmidt
Bone Marrow Transplant 40: 1033-1037; advance online publication, September 24, 2007; doi:10.1038/sj.bmt.1705857
Autografting
The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma FREE
R N Pham, T A Gooley, G E Keeney, O W Press, J M Pagel, H A Greisman, W I Bensinger, L A Holmberg, S H Petersdorf, D G Maloney and A K Gopal
Bone Marrow Transplant 40: 1039-1044; advance online publication, October 8, 2007; doi:10.1038/sj.bmt.1705864
High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working Party FREE
U De Giorgi, D Blaise, A Lange, P Viens, M Marangolo, A Madroszyk, M Brune, B V Afanassiev, G Rosti and T Demirer
Bone Marrow Transplant 40: 1045-1048; advance online publication, October 8, 2007; doi:10.1038/sj.bmt.1705880
Post-Transplant Events
High rate of discordance between clinical and autopsy diagnoses in blood and marrow transplantation FREE
M D Seftel, M Ho, D Pruthi, S Orbanski, M Rubinger, B Schacter, D Szwajcer, C Bredeson and A A Demers
Bone Marrow Transplant 40: 1049-1053; advance online publication, September 17, 2007; doi:10.1038/sj.bmt.1705855
Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation FREE
A Bjorklund, J Aschan, M Labopin, M Remberger, O Ringden, J Winiarski and P Ljungman
Bone Marrow Transplant 40: 1055-1062; advance online publication, September 24, 2007; doi:10.1038/sj.bmt.1705856
The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product FREE
R Cordoba, R Arrieta, A Kerguelen and F Hernandez-Navarro
Bone Marrow Transplant 40: 1063-1067; advance online publication, October 1, 2007; doi:10.1038/sj.bmt.1705861
Graft-versus-Tumour Effects
Anti-leukaemic role of acute GvHD after unrelated haematopoietic stem cell transplantation in intermediate- to high-risk acute myelogenous leukaemia FREE
H-J Kim, W-S Min, K-S Eom, B-S Cho, S-Y Kim, J-N Bok, K-S Kim, C-K Min, S Lee, S-G Cho, D-W Kim, J-W Lee and C-C Kim
Bone Marrow Transplant 40: 1069-1074; advance online publication, October 8, 2007; doi:10.1038/sj.bmt.1705873
Transplant Technology
Terminology and labeling of cellular products: 1. Standards FREE
P Ashford, P Distler, A Gee, A Lankester, S Larsson, I Feller, K Loper, D Pamphilon, L Poston, F Rabe, I Slaper-Cortenbach, Z Szczepiorkowski and P Warkentin
Bone Marrow Transplant 40: 1075-1083; advance online publication, October 1, 2007; doi:10.1038/sj.bmt.1705858
Transplant Technology
Terminology and labeling of cellular products–2: Implementation plan FREE
P Ashford, P Distler, A Gee, A Lankester, S Larsson, I Feller, K Loper, D Pamphilon, L Poston, F Rabe, I Slaper-Cortenbach, Z Szczepiorkowski and P Warkentin
Bone Marrow Transplant 40: 1085-1090; advance online publication, October 1, 2007; doi:10.1038/sj.bmt.1705859
Letters to the Editor
Thiotepa-based reduced intensity conditioning regimen: a 10 year follow up FREE
A Bacigalupo, A M Raiola, T Lamparelli, F Gualandi, D Occhini, S Bregante, A Ibatici, C di Grazia, A Dominietto, B Bruno, M T Van Lint and F Frassoni
Bone Marrow Transplant 40: 1091-1093; advance online publication, October 1, 2007; doi:10.1038/sj.bmt.1705863
Central nervous system graft-versus-host disease: consider progressive multifocal leukoencephalopathy among the differential diagnoses FREE
D Focosi, R E Kast, F Maggi, S Galimberti, F Papineschi, M Petrini and L Ceccherini-Nelli
Bone Marrow Transplant 40: 1095-1096; advance online publication, October 8, 2007; doi:10.1038/sj.bmt.1705874
